bendamustine hydrochloride has been researched along with Head and Neck Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Austein, T; Demme, B | 1 |
Adamietz, IA; Bormeth, SB; Böttcher, HD; Mose, S; Rahn, AN; Schilcher, RB | 1 |
2 other study(ies) available for bendamustine hydrochloride and Head and Neck Neoplasms
Article | Year |
---|---|
Uncommon recurrence of follicular lymphoma.
Topics: Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Head and Neck Neoplasms; Humans; Lymphoma, Follicular; Male; Nitrogen Mustard Compounds; Prednisone; Remission Induction; Rituximab; Skin Neoplasms | 2012 |
[Palliative radiochemotherapy with Bendamustin for advanced recurrent head and neck tumors].
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Nitrogen Mustard Compounds; Palliative Care; Radiotherapy Dosage; Radiotherapy, Adjuvant; Treatment Outcome | 2001 |